ClinicalTrials.gg
CompletedNCT01097915gustinpropUpdated Dec 21, 2018Results posted

Gustin Gene Polymorphism and 6-n-propylthiouracil (PROP) Taste

An observational study in Dysgeusia, sponsored by University of Cagliari. Completed at 1 site in Italy. Open to participants aged 20 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-12-21.

Sponsored by University of Cagliari · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
170
Ages
20 Years to 30 Years
Sex
All
01

Study summary

The investigators evaluate the possible association of PROP taste with gustin gene polymorphism rs2274333 (A/G), salivary zinc ion concentration and BMI. In addition, it has also been evaluated PROP taste sensitivity by recording monophasic potentials from the tongue.

Read the detailed description

The investigators evaluate the possible association of PROP taste with gustin gene polymorphism rs2274333 (A/G), salivary zinc ion concentration and BMI.

Furthermore, we apply direct measures of the gustatory system activation following stimulation with PROP, obtained by electrophysiological recordings from the tongue of subjects classified for taster status, genotyped for the specific receptor gene (TAS2R38), and in which papilla density was determined.

02

Conditions studied

  • Dysgeusia

Browse trials for

Keywords

  • PROP taste sensitivity
  • Gustin (CAVI) polymorphism
  • Salivary zinc
  • BMI
  • Electrophysiological recording from the tongue
03

In context

Dysgeusia

52 studies on the registry are indexed under Dysgeusia; 12 are open to participants now.

This study's enrollment of 170 is above the median of 104 across 22 observational studies indexed under Dysgeusia.

Browse Dysgeusia studies →

Lead sponsor

University of Cagliari is the lead sponsor of 85 studies on the registry; 17 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Seventy-five non-smoking volunteers (28 men and 47 women) were recruited for the study. Participants between 20-30 years were eligible for the study. Thresholds for the 4 basic tastes were evaluated in all subjects in order to rule out any gustatory impairment. The volunteers showed no variation of body weight > 5 kg over the last 3 mo. They were not following a prescribed diet or using medications that might interfere with taste perception; none had food allergies. They were assessed for cognitive eating behaviours using the Three-Factor Eating Questionnaire

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • no variation of body weight > 5 kg over the last 3 mo within 20-25 Age between 20-30

Exclusion criteria

Exclusion Criteria:

  • gustatory impairment following a prescribed diet or using medications that might interfere with taste perception food allergies smokers
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
170 participants (actual)
Biospecimen retention
Samples with dna

Groups and cohorts

  • PROP taste sensitivity

    PROP Sensitive and non sensitive individuals are defined as "Tasters" and "Non-tasters", respectively. Taster are further divided in "Super-taster" who perceived PROP as extremely bitter and "Medium tasters" who perceived PROP as moderately bitter.

06

What researchers measure

Primary outcomes

  1. Association Between Gustin Gene Polymorphism and PROP Sensitivity

    We examine associations between PROP status and the polymorphism rs2274333 (A/G) of the gene that codify for the salivary protein, gustin/CA6, Which has been suggested as a trophic factor that promotes growth and development of taste buds by acting on taste bud stem cells. The intensity of taste perception evoked by PROP and NaCl solutions was estimated to evaluate PROP taster status and molecular analysis of the gustin gene polymorphism was performed in individuals classified by PROP status using PCR techniques.

    Time frame: 7 months

Secondary outcomes

  1. Association Between PROP Sensitivity and Saliva Zinc Ion Concentration

    Since the enzymatic function of gustin (CA6) depends upon the presence of Zn at its active site we measured the salivary zinc ion concentration in subjects classified as super-taster, medium taster and non-taster.The salivary Zn2+ concentration was measured with a QuantiChromTM zinc Assay kit (Gentaur, Brussels, Belgium) where the color intensity is directly proportional to the Zn2+ concentration in the sample.

    Time frame: 7 months

  2. Association Between PROP Sensitivity and BMI

    Since individual ability to taste PROP may be correlated with BMI, we determined BMI (kg/m\^2) in subjects classified as super-taster, medium taster and non-taster.Weight (kg) and height (m) were recorded for each subject.

    Time frame: 7 months

  3. Electrophysiological Recordings From the Tongue for the Objective Evaluation of Individual Variations of 6-n-propylthiouracil (PROP) Sensitivity

    electrophysiological recordings from the tongue of 43 subjects classified for their taste sensitivity to 6-n- propyltiouracil (PROP) and genotyped for the specific receptor gene, TAS2R38. Density of fungiform papillae was also determined in each subject. The biopotentials were recorded by means of differential electrophysiological derivations between two silver electrodes, one in contact with the ventral surface of the tongue and one in perfect adhesion with the dorsal surface.

    Time frame: 1 year

  4. Association Between PROP Sensitivity and Fungiform Papilla Density

    43 subjects were classified for their taste sensitivity to 6-n- propyltiouracil (PROP) and density of fungiform papillae was determined in each subject.

    Time frame: 6 months

  5. Taste Perception of Sweet, Sour, Salty, Bitter and Umami and Changes Due to L-Arginine Supplementation, as a Functin of Genetic Ability to Taste PROP.

    Taste perception was assessed by testing the ability to recognize, and the responsiveness to, representative solutions of the five taste qualities, also when supplemented with L-Arg, in subjects classified as PROP-tasters.

    Time frame: 8 months

07

Results

Posted Dec 21, 2016

Participant flow

Participant flow — Overall Study
MilestoneSuper TastersMedium TastersNon Tasters
Started507050
Completed272820
Not completed234230

Outcome measures

PrimaryAssociation Between Gustin Gene Polymorphism and PROP Sensitivity

We examine associations between PROP status and the polymorphism rs2274333 (A/G) of the gene that codify for the salivary protein, gustin/CA6, Which has been suggested as a trophic factor that promotes growth and development of taste buds by acting on taste bud stem cells. The intensity of taste perception evoked by PROP and NaCl solutions was estimated to evaluate PROP taster status and molecular analysis of the gustin gene polymorphism was performed in individuals classified by PROP status using PCR techniques.

Time frame:
7 months
Reported as:
Number · percentage of participants
Association Between Gustin Gene Polymorphism and PROP Sensitivity
percentage of participantsSuper TastersMedium TastersNon Tasters
Genotype AA85.1950.9925.00
Genotype AG14.8135.7120
Genotype GG014.2955
Allele A92.5967.8635
Allele G7.4032.1465
Statistical analysis
  • Super Tasters vs Medium Tasters vs Non Tasters · Fisher Exact · p = <0.01
SecondaryAssociation Between PROP Sensitivity and Saliva Zinc Ion Concentration

Since the enzymatic function of gustin (CA6) depends upon the presence of Zn at its active site we measured the salivary zinc ion concentration in subjects classified as super-taster, medium taster and non-taster.The salivary Zn2+ concentration was measured with a QuantiChromTM zinc Assay kit (Gentaur, Brussels, Belgium) where the color intensity is directly proportional to the Zn2+ concentration in the sample.

Time frame:
7 months
Reported as:
Mean · microg/dl
Association Between PROP Sensitivity and Saliva Zinc Ion Concentration
microg/dlSuper-tastersMedium TastersNon-tasters
Association Between PROP Sensitivity and Saliva Zinc Ion Concentration57.3 ± 1389.5 ± 17.2149.64 ± 26.4
Statistical analysis
  • Super-tasters vs Medium Tasters vs Non-tasters · ANOVA · p = <0.004
SecondaryAssociation Between PROP Sensitivity and BMI

Since individual ability to taste PROP may be correlated with BMI, we determined BMI (kg/m\^2) in subjects classified as super-taster, medium taster and non-taster.Weight (kg) and height (m) were recorded for each subject.

Time frame:
7 months
Reported as:
Mean · Kg/m^2
Association Between PROP Sensitivity and BMI
Kg/m^2Super-tastersMedium TastersNon-tasters
Association Between PROP Sensitivity and BMI20.3 ± 0.4820.76 ± 0.5822.58 ± 0.84
Statistical analysis
  • Super-tasters vs Medium Tasters vs Non-tasters · ANCOVA · p = <0.048the three factors of the Stunkard and Messick Questionnaire were considered as covariates.
SecondaryElectrophysiological Recordings From the Tongue for the Objective Evaluation of Individual Variations of 6-n-propylthiouracil (PROP) Sensitivity

electrophysiological recordings from the tongue of 43 subjects classified for their taste sensitivity to 6-n- propyltiouracil (PROP) and genotyped for the specific receptor gene, TAS2R38. Density of fungiform papillae was also determined in each subject. The biopotentials were recorded by means of differential electrophysiological derivations between two silver electrodes, one in contact with the ventral surface of the tongue and one in perfect adhesion with the dorsal surface.

Time frame:
1 year
Reported as:
Mean · mV
Electrophysiological Recordings From the Tongue for the Objective Evaluation of Individual Variations of 6-n-propylthiouracil (PROP) Sensitivity
mVSuper-TasterMedium TasterNon Taster
Electrophysiological Recordings From the Tongue for the Objective Evaluation of Individual Variations of 6-n-propylthiouracil (PROP) Sensitivity97,08867 ± 6,53819175,42000 ± 6,53819148,48231 ± 7,023144
Statistical analysis
  • Super-Taster vs Medium Taster vs Non Taster · ANOVA · p = < 0.00001
SecondaryAssociation Between PROP Sensitivity and Fungiform Papilla Density

43 subjects were classified for their taste sensitivity to 6-n- propyltiouracil (PROP) and density of fungiform papillae was determined in each subject.

Time frame:
6 months
Reported as:
Mean · No./cm2
Association Between PROP Sensitivity and Fungiform Papilla Density
No./cm2Super-tastersMedium TastersNon-tasters
Association Between PROP Sensitivity and Fungiform Papilla Density51.66 ± 5.2533.49 ± 5.2618.53 ± 7.023
Statistical analysis
  • Super-tasters vs Medium Tasters vs Non-tasters · ANOVA · p = < 0.00001
SecondaryTaste Perception of Sweet, Sour, Salty, Bitter and Umami and Changes Due to L-Arginine Supplementation, as a Functin of Genetic Ability to Taste PROP.

Taste perception was assessed by testing the ability to recognize, and the responsiveness to, representative solutions of the five taste qualities, also when supplemented with L-Arg, in subjects classified as PROP-tasters.

Time frame:
8 months
Reported as:
Count of participants · Participants
Taste Perception of Sweet, Sour, Salty, Bitter and Umami and Changes Due to L-Arginine Supplementation, as a Functin of Genetic Ability to Taste PROP.
ParticipantsPrimary Taste QualityPrimary Taste Quality Supplemented With L-Arg
sucrose — Undet Threshold182
sucrose — Correct identification4020
sucrose — Incorrect teste response642
NaCl — Undet Threshold11
NaCl — Correct identification5241
NaCl — Incorrect teste response1122
Citric Acid — Undet Threshold54
Citric Acid — Correct identification4947
Citric Acid — Incorrect teste response1013
caffeine — Undet Threshold66
caffeine — Correct identification5656
caffeine — Incorrect teste response22
MSG — Undet Threshold70
MSG — Correct identification2633
MSG — Incorrect teste response3131
Statistical analysis
  • Primary Taste Quality vs Primary Taste Quality Supplemented With L-Arg · Chi-squared · p = < 0.00001

Adverse events

Collected over 7 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Super Tasters—0/27 (0%)0/27 (0%)
Medium Tasters—0/28 (0%)0/28 (0%)
Non Tasters—0/20 (0%)0/20 (0%)

Baseline characteristics

Caucasian and were originally from Sardinia, Italy. Participants between 20-30 years were eligible for the study.

Age, Categorical
Age, Categorical(Participants)Super TastersMedium TastersNon TastersTotal
<=18 years0000
Between 18 and 65 years507050170
>=65 years0000
Age, Continuous
Age, Continuous(years)Super TastersMedium TastersNon TastersTotal
Mean25 ± 725 ± 825 ± 625 ± 7
Sex: Female, Male
Sex: Female, Male(Participants)Super TastersMedium TastersNon TastersTotal
Female354034109
Male15301661
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Super TastersMedium TastersNon TastersTotal
American Indian or Alaska Native0000
Asian0000
Native Hawaiian or Other Pacific Islander0000
Black or African American0000
White507050170
More than one race0000
Unknown or Not Reported0000
Region of Enrollment
Region of Enrollment(participants)Super TastersMedium TastersNon TastersTotal
Italy507050170
healthy volunteers
healthy volunteers(participants)Super TastersMedium TastersNon TastersTotal
Number507050170
08

Study locations

1 site
  • Sezione di Farmacologia Clinica del Dipartimento di Neuroscienze, San Giovanni di Dio Azienda Ospedaliero Universitaria di Cagliari
    Cagliari, Ca 09124, Italy
09

References and documents

Publications

  • Padiglia A, Zonza A, Atzori E, Chillotti C, Calo C, Tepper BJ, Barbarossa IT. Sensitivity to 6-n-propylthiouracil is associated with gustin (carbonic anhydrase VI) gene polymorphism, salivary zinc, and body mass index in humans. Am J Clin Nutr. 2010 Sep;92(3):539-45. doi: 10.3945/ajcn.2010.29418. Epub 2010 Jul 14. PubMed 20631203 ↗

Individual participant data

Plan to share: Undecided — Data of this study are available from the principal investigator of this study upon request

10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Oct 2009, a primary completion of Dec 2009 and a completion of Jun 2016. It does not say whether these dates are actual or estimated.

Results were first posted in Dec 2016, 7 years after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 1, 2010
First posted
Apr 2, 2010
Start
Oct 2009
Primary completionActual
Dec 2009
CompletionActual
Jun 2016
Results first posted
Dec 21, 2016
Last update
Dec 21, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 21, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01097915
Lead sponsor
University of Cagliari
Responsible party
Iole Tomassini Barbarossa (Associate Professor, University of Cagliari) — Principal investigator
First posted
Apr 2, 2010
Start date
Oct 2009
Primary completion
Dec 2009
Completion
Jun 2016
Results posted
Dec 21, 2016
Last update
Dec 21, 2018

Study contacts

Iole Tomassini Barbarossa, PhD
principal investigator · Dip. Scienze Biomediche Sezione di Fisiologia Università di Cagliari

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion